Covering the assessment and management of chronic kidney disease, including pharmacotherapy
Covering the assessment and management of anaemia in people with chronic kidney disease
Recommendations on comprehensive care, glycaemic monitoring and targets, lifestyle and antihyperglycaemic interventions, and approaches to self-management and optimal models of care
This Guidelines summary covers the provision of care for patients requiring dialysis in the context of the COVID-19 outbreak
This COVID-19 rapid guideline aims to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
This animation has been developed and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals.
432-GB-2100230 June 2021